Top Stories

FDA approval brings remote programming for Abbott’s deep brain stimulation device

The digitization of implanted devices continues apace. On Monday, Abbott announced the launch of its FDA-approved NeuroSphere Virtual Clinic by which patients implanted with the company’s deep brain stimulation devices for Parkinson’s Disease, essential tremor and chronic pain can have their devices programmed remotely without having to travel to a specialist. Hailing this virtual capability, […]